Intelligent Investor

Bioxyne Limited (ASX: BXN) - Announcements

- Current share price for BXN : $0.006

ASX company news and announcements for Bioxyne Limited (BXN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bioxyne Limited (BXN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bioxyne Limited (BXN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bioxyne Limited (BXN)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$12 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 10:02AM $0.008 $0.006 $0.007 fallen by 25%
$12 Cleansing Notice 22 Apr 2024 8:33AM $0.008 $0.006 $0.007 fallen by 25%
$12 Application for quotation of securities - BXN 22 Apr 2024 8:32AM $0.008 $0.006 $0.007 fallen by 25%
$12 Proposed issue of securities - BXN 18 Apr 2024 9:40AM $0.009 $0.006 $0.007 fallen by 33.33%
$12 Bioxyne Receives Firm Commitments to Raise $1.45 Million 18 Apr 2024 8:54AM $0.009 $0.006 $0.007 fallen by 33.33%
$12 Bioxyne to Host Webinar on 28 March 2024 25 Mar 2024 2:23PM $0.010 $0.006 $0.007 fallen by 40%
$12 Investor Presentation 25 Mar 2024 9:57AM $0.010 $0.006 $0.007 fallen by 40%
$12 Notification regarding unquoted securities - BXN 22 Mar 2024 2:28PM $0.009 $0.006 $0.007 fallen by 33.33%
$12 Notification of cessation of securities - BXN 22 Mar 2024 2:22PM $0.009 $0.006 $0.007 fallen by 33.33%
$12 Half Yearly Report and Accounts 29 Feb 2024 12:38PM $0.011 $0.006 $0.007 fallen by 45.45%
$12 BXN Awarded GMP Manufacturing License for Medical Cannabis 5 Feb 2024 8:19AM $0.012 $0.006 $0.007 fallen by 50%
$12 Quarterly Report Listing Rule 4.7C.3 5 Feb 2024 8:18AM $0.012 $0.006 $0.007 fallen by 50%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jan 2024 8:16AM $0.014 $0.006 $0.007 fallen by 57.14%
$12 Final Director's Interest Notice 17 Nov 2023 4:08PM $0.012 $0.006 $0.007 fallen by 50%
$12 Retirement of Director 17 Nov 2023 4:08PM $0.012 $0.006 $0.007 fallen by 50%
$12 Results of Meeting 17 Nov 2023 4:01PM $0.012 $0.006 $0.007 fallen by 50%
$12 Annual General Meeting Presentation 17 Nov 2023 9:51AM $0.012 $0.006 $0.007 fallen by 50%
$12 Change in substantial holding 6 Nov 2023 9:59AM $0.013 $0.006 $0.007 fallen by 53.85%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2023 4:25PM $0.011 $0.006 $0.007 fallen by 45.45%
$12 BLS Builds Medicinal Business In Australia 19 Oct 2023 10:19AM $0.011 $0.006 $0.007 fallen by 45.45%
$12 Letter to Shareholders re Annual General Meeting Notice 18 Oct 2023 3:38PM $0.011 $0.006 $0.007 fallen by 45.45%
$12 Notice of Annual General Meeting/Proxy Form 18 Oct 2023 3:38PM $0.011 $0.006 $0.007 fallen by 45.45%
$12 Change of Director's Interest Notice 17 Oct 2023 8:12PM $0.011 $0.006 $0.007 fallen by 45.45%
$12 Change of Director's Interest Notice 9 Oct 2023 9:31AM $0.012 $0.006 $0.007 fallen by 50%
$12 AGM Date 2023 and Closing Date for Director Nominations 5 Oct 2023 8:40AM $0.012 $0.006 $0.007 fallen by 50%

1 - 25 of 311 results

Page 1 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.